In Vitro Diagnostics Business Outlook, 2026 - Focus on Veterinary Diagnostics - Volume 5, Issue 3
Description
The in vitro diagnostics (IVD) industry is a cornerstone of modern healthcare, empowering clinicians to detect disease, monitor health conditions, and guide treatment decisions with precision. As healthcare continues to evolve—driven by rising rates of chronic conditions such as diabetes and cardiovascular disease, along with ongoing and emerging infectious threats—the IVD market is undergoing constant change and growth.
In Vitro Diagnostics Business Outlook is a monthly intelligence publication designed to help industry professionals stay current in this fast-moving environment. Delivered in 12 issues annually, each issue focuses on a different segment of the IVD industry, providing timely insights, exclusive data, and in-depth analysis.
Featured Content
Each monthly issue provides:
2026 Editorial Focus
Topics vary month to month, reflecting evolving industry priorities. In 2026, subscribers can expect issues dedicated to:
Please Note: Single user allows for up to 3 users for this report.
In Vitro Diagnostics Business Outlook is a monthly intelligence publication designed to help industry professionals stay current in this fast-moving environment. Delivered in 12 issues annually, each issue focuses on a different segment of the IVD industry, providing timely insights, exclusive data, and in-depth analysis.
Featured Content
Each monthly issue provides:
- Market Data and Forecasts
- Comprehensive Market View
- M&A Activity Tracking
- Industry & Region Watch
- In-Depth News Analysis
2026 Editorial Focus
Topics vary month to month, reflecting evolving industry priorities. In 2026, subscribers can expect issues dedicated to:
- Reimbursement trends
- Quality control reagents
- Cardiac markers
- STI point-of-care testing
- Non-respiratory infectious diseases
- An overall IVD market trend analysis
- A forward-looking forecast of the respiratory testing market through 2027
- And more!
Please Note: Single user allows for up to 3 users for this report.
Table of Contents
43 Pages
- MARKET ANALYSIS: VETERINARY DIAGNOSTICS
- OVERVIEW OF VETERINARY DIAGNOSTICS
- VETERINARY DIAGNOSTICS MARKET OUTLOOK
- Figure 1: Veterinary Diagnostics Market, by Segment, 2025 and 2030 ($ million) [Companion, Food]
- COMPANY BRIEFS: VETERINARY DIAGNOSTICS
- IDEXX Laboratories
- Mars Petcare
- Zoetis
- VENDOR MARKET SHARE: VETERINARY DIAGNOSTICS
- Figure 2: Competitive Market Share Global Veterinary Diagnostics, by Leading Vendors, Estimated 2025 (%)
- REGIONAL MARKET: VETERINARY DIAGNOSTICS
- Figure 3: Veterinary Diagnostic Market, Geographic Distribution of Sales, 2020-2030 ($ million) [Asia Pacific, Europe, Latin America, United States Rest of World]
- EXECUTIVE NEWS BRIEFING
- BRIEFINGS
- Mainz Biomed Strengthens Cancer Detection Financing
- Reacta Healthcare Appoints New Chairman of the Board
- Trinity Biotech Secures $25 Million Financing
- Abram Scientific Closes $11.75 Million Series A Funding
- Quest Diagnostics Appoints New Senior Vice President, Chief Strategy and M&A Officer
- Dexcom Appoints New Member to Board of Directors
- Babson Diagnostics Names News CEO
- Castle Biosciences Opens New Corporate Headquarters
- Owkin Spinout Waiv Secures $33 Million for AI
- BRUKER DELIVERED OVERALL REVENUE GROWTH IN 2025
- Table 1: Bruker Product Revenues Performance, by Business Product Group, FY2025 ($ million)
- Figure 4: Bruker Corporation Sales, by Business Product Group, 2024 vs. 2025 ($ million)
- Figure 5: Bruker Corporation 2024 and 2025 Regional Sales Breakdown Distribution, 2024 vs. 2025 [Asia Pacific, Europe, United States, Other)
- DIAGNOSTIC MARKET MERGERS, ACQUISITIONS, AND PARTNERSHIP DEALS
- PARTNERSHIPS AND COLLABORATIONS
- MERGERS AND ACQUISITIONS
- Table 2: Recent Diagnostic Market Mergers, Acquisitions, and Partnership Deals
- INDUSTRY WATCH
- INDUSTRY WATCH COVID-19/FLU UPDATE
- REGION WATCH
- SOUTH AFRICA
- Figure 6: South Africa Population Pyramid, 2025 and 2055 Estimates
- Figure 7: South Africa GDP, Composition by Sector (Agriculture, Industry, Services) – Range (%)
- Figure 8: South Africa IVD Market Share, by Broad IVD Segment, 2025 (%) [Core Lab, Histology/Cytology, Immunoassays, Microbiology/Virology, Point-of-Care, Other Segments]
- BROAD-BASED COMPANY ANNOUNCEMENTS
- ANNOUNCEMENTS
- Bio-Techne Gains CE-IVD Marking for Its Ella Platform
- Breath Diagnostics Receives FDA Breakthrough Device Designation
- Biomerica Lands Approval in Vietnam for EZ Detect
- NG Biotech and Hardy Diagnostics Granted FDA Breakthrough Device Designation
- Diasorin Secures FDA Approval of LIAISON QuantiFERON-TB Gold Plus II
- Meridian Bioscience Lands IVDR Certification for Alethia Molecular Assay Portfolio
- NeoGenomics Launches RaDaR ST
- Bruker Launches CellScape XR
- MiraDx Launches PROSTOX Standard Genetic Test
- Techcyte Gains CE Marking for Fusion AP Platform
- PathAI Granted Breakthrough Device Designation for PathAssist Derm
- MeMed Secures Breakthrough Device Designation
- Natera Launches Zenith Genomics
- Roche Nets CE Marking for First Immunoassay Test for Alzheimer’s Disease
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
